Steve Duffy

Digital Content Editor

Most Recent Articles by Steve Duffy

Positive Results for Ceftolozane/Tazobactamin Phase 3 Study of Ventilated HABP, VABP Patients

Positive Results for Ceftolozane/Tazobactamin Phase 3 Study of Ventilated HABP, VABP Patients

By

The full findings from the study will be presented at a future scientific conference; Merck plans to include the data in a supplemental New Drug Application for Zerbaxa which will be submitted to the Food and Drug Administration.

AAP Issues Updated Influenza Vaccine Recommendations

AAP Issues Updated Influenza Vaccine Recommendations

By

According to the Centers for Disease Control and Prevention (CDC), the 2017-2018 flu season was one of the most severe - excluding pandemics - on record.

Tolerability of Switching to Long-acting Cabotegravir Plus Rilpivirine From Current HIV-1 Regimen

Tolerability of Switching to Long-acting Cabotegravir Plus Rilpivirine From Current HIV-1 Regimen

By

The ATLAS study enrolled 570 patients infected with HIV-1; participants were randomized to either the experimental or active comparator arms.

Could Zika Virus Be a Potential Treatment for Neuroblastoma?

Could Zika Virus Be a Potential Treatment for Neuroblastoma?

By

Even with intensive therapy, survival among neuroblastoma patients is poor, indicating a need for alternative treatments.

Juluca Maintains Viral Suppression in HIV Patients Through 100 Weeks

Juluca Maintains Viral Suppression in HIV Patients Through 100 Weeks

By

The SWORD 1 and SWORD 2 trials enrolled 1027 HIV-infected and virologically suppressed adults; both trials had an early (Day 1 to Week 52) and late (Week 52 to Week 148) switch phase.

More Articles by Steve Duffy

Sign Up for Free e-newsletters